RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CNBX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Cannabics Pharma stock price on Thursday moving between $0.0122 and $0.0159
(Updated on Mar 28, 2024)

Hold candidate since Mar 28, 2024 PDF

The Cannabics Pharma stock price gained 13.57% on the last trading day (Thursday, 28th Mar 2024), rising from $0.0140 to $0.0159. During the last trading day the stock fluctuated 30.33% from a day low at $0.0122 to a day high of $0.0159. The price has fallen in 4 of the last 10 days and is down by -0.62% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 8 thousand more shares were traded than the day before. In total, 10 thousand shares were bought and sold for approximately $162.28 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.65% during the next 3 months and, with a 90% probability hold a price between $0.0091 and $0.0168 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CNBX Signals & Forecast

The Cannabics Pharma stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0144 and $0.0138. A breakdown below any of these levels will issue sell signals. Cannabics Pharma has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 13, 2024, and so far it has fallen -6.47%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Cannabics Pharma stock

Cannabics Pharma finds support from accumulated volume at $0.0155 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0037 between high and low, or 30.33%. For the last week, the stock has had daily average volatility of 25.89%.

Our recommended stop-loss: $0.0151 (-4.96%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 11 days ago.)

Trading Expectations (CNBX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Cannabics Pharma to open at $0.0147, and during the day (based on 14 day Average True Range), to move between $0.0132 and $0.0186, which gives a possible trading interval of +/-$0.0027 (+/-17.24%) up or down from last closing price. If Cannabics Pharma takes out the full calculated possible swing range there will be an estimated 34.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0162 (1.89%) than the support at $0.0155 (2.52%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Cannabics Pharma stock A Buy?

Cannabics Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.331 Hold/Accumulate Upgraded

Predicted Opening Price for Cannabics Pharma of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.0147 ( 7.76%) $0.0159

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CNBX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0184 15.51 %
R2 0.0170 6.62 %
R1 0.0161 1.13 %
Current price: 0.0159
Support S1 0.0133 -16.65 %
S2 0.0124 -22.14 %
S3 0.0110 -31.03 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.0180 13.21 %
R2 0.0165 3.77 %
R1 0.0162 1.89 %
Current price 0.0159
Support S1 0.0155 -2.52%
S2 0.0150 -5.91%
S3 0.0125 -21.38%

FAQ

What is the symbol for Cannabics Pharma Stock and on which exchange is it traded?
The symbol for Cannabics Pharma is CNBX and it is traded on the OTCBB (OTC Bulletin Board).

Should I buy or sell Cannabics Pharma Stock?
Cannabics Pharma holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Cannabics Pharma Stock?
Cannabics Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cannabics Pharma Stock.

What's the current price of Cannabics Pharma Stock?
As of the end of day on the 2024-03-28, the price of an Cannabics Pharma (CNBX) share was $0.0159.

What is the 52-week high and low for Cannabics Pharma Stock?
The 52-week high for Cannabics Pharma Stock is $0.0980 and the 52-week low is $0.0085.

What is the market capitalization of Cannabics Pharma Stock?
As of the 2024-03-28, the market capitalization of Cannabics Pharma is 494.671K.

When is the next earnings date for Cannabics Pharma?
The upcoming earnings date for Cannabics Pharma is Apr 14, 2024.
Click to get the best stock tips daily for free!

About Cannabics Pharma

Cannabics Pharma CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal p... CNBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT